Search Results - Ryška, Aleš
- Showing 1 - 20 results of 27
- Go to Next Page
-
1
-
2
-
3
The leading role of pathology in assessing the somatic molecular alterations of cancer: Position Paper of the European Society of Pathology by Matias-Guiu, Xavier, Stanta, Giorgio, Carneiro, Fátima, Ryska, Ales, Hoefler, Gerald, Moch, Holger
Published 2020Text -
4
Are ENT1/ENT1, NOTCH3, and miR-21 Reliable Prognostic Biomarkers in Patients with Resected Pancreatic Adenocarcinoma Treated with Adjuvant Gemcitabine Monotherapy? by Jiraskova, Lucie, Ryska, Ales, Duintjer Tebbens, Erik Jurjen, Hornychova, Helena, Cecka, Filip, Staud, Frantisek, Cerveny, Lukas
Published 2019Text -
5
-
6
-
7
HIF2A GAIN-OF-FUNCTION MUTATIONS DETECTED IN DUODENAL GANGLIOCYTIC PARAGANGLIOMA by Zhuang, Zhengping, Yang, Chunzhang, Ryska, Ales, Ji, Yuan, Hou, Yingyong, Graybill, Sky D., Bullova, Petra, Lubensky, Irina A., Klöppel, Günter, Pacak, Karel
Published 2016Text -
8
NSCLC molecular testing in Central and Eastern European countries by Ryska, Ales, Berzinec, Peter, Brcic, Luka, Cufer, Tanja, Dziadziuszko, Rafal, Gottfried, Maya, Kovalszky, Ilona, Olszewski, Włodzimierz, Oz, Buge, Plank, Lukas, Timar, Jozsef
Published 2018Text -
9
Autoimmunity, cancer and COVID-19 abnormally activate wound healing pathways: critical role of inflammation by Gál, Peter, Brábek, Jan, Holub, Michal, Jakubek, Milan, Šedo, Aleksi, Lacina, Lukáš, Strnadová, Karolína, Dubový, Petr, Hornychová, Helena, Ryška, Aleš, Smetana, Karel
Published 2022Text -
10
Non‐Small Cell Lung Cancer in Countries of Central and Southeastern Europe: Diagnostic Procedures and Treatment Reimbursement Surveyed by the Central European Cooperative Oncology... by Ryska, Ales, Buiga, Rares, Fakirova, Albena, Kern, Izidor, Olszewski, Włodzimierz, Plank, Lukas, Seiwerth, Sven, Toth, Erika, Zivka, Eri, Thallinger, Christiane, Zielinski, Christoph, Brcic, Luka
Published 2018Text -
11
A stitch in time saves nine: external quality assessment rounds demonstrate improved quality of biomarker analysis in lung cancer by Keppens, Cleo, Tack, Véronique, Hart, Nils ‘t, Tembuyser, Lien, Ryska, Ales, Pauwels, Patrick, Zwaenepoel, Karen, Schuuring, Ed, Cabillic, Florian, Tornillo, Luigi, Warth, Arne, Weichert, Wilko, Dequeker, Elisabeth
Published 2018Text -
12
Impact of Hormone Receptor Status on the Behaviour of HER2+ Breast Cancer by KOLAROVA, IVETA, DUSEK, LADISLAV, RYSKA, ALES, ODRAZKA, KAREK, DOLEZEL, MARTIN, VANASEK, JAROSLAV, MELICHAR, BOHUSLAV, PETERA, JIRI, BUCHLER, TOMAS, VOSMIK, MILAN, PETRAKOVA, KATARINA, TERAROVA, PETRA, VILASOVA, ZDENA, JARKOVSKY, JIRI
Published 2020Text -
13
Expert opinion on NSCLC small specimen biomarker testing — Part 2: Analysis, reporting, and quality assessment by Penault-Llorca, Frédérique, Kerr, Keith M., Garrido, Pilar, Thunnissen, Erik, Dequeker, Elisabeth, Normanno, Nicola, Patton, Simon J., Fairley, Jenni, Kapp, Joshua, de Ridder, Daniëlle, Ryška, Aleš, Moch, Holger
Published 2022Text -
14
Neoplastic cell percentage estimation in tissue samples for molecular oncology: recommendations from a modified Delphi study by Dufraing, Kelly, van Krieken, J Henricus, De Hertogh, Gert, Hoefler, Gerald, Oniscu, Anca, Kuhlmann, Tine P, Weichert, Wilko, Marchiò, Caterina, Ristimäki, Ari, Ryška, Aleš, Scoazec, Jean‐Yves, Dequeker, Elisabeth
Published 2019Text -
15
Tumor-infiltrating B cells affect the progression of oropharyngeal squamous cell carcinoma via cell-to-cell interactions with CD8(+) T cells by Hladíková, Kamila, Koucký, Vladimír, Bouček, Jan, Laco, Jan, Grega, Marek, Hodek, Miroslav, Zábrodský, Michal, Vošmik, Milan, Rozkošová, Kateřina, Vošmiková, Hana, Čelakovský, Petr, Chrobok, Viktor, Ryška, Aleš, Špíšek, Radek, Fialová, Anna
Published 2019Text -
16
Testing for ROS1 in non-small cell lung cancer: a review with recommendations by Bubendorf, Lukas, Büttner, Reinhard, Al-Dayel, Fouad, Dietel, Manfred, Elmberger, Göran, Kerr, Keith, López-Ríos, Fernando, Marchetti, Antonio, Öz, Büge, Pauwels, Patrick, Penault-Llorca, Frédérique, Rossi, Giulio, Ryška, Aleš, Thunnissen, Erik
Published 2016Text -
17
Calreticulin exposure correlates with robust adaptive antitumor immunity and favorable prognosis in ovarian carcinoma patients by Kasikova, Lenka, Hensler, Michal, Truxova, Iva, Skapa, Petr, Laco, Jan, Belicova, Lucie, Praznovec, Ivan, Vosahlikova, Sarka, Halaska, Michael J., Brtnicky, Tomas, Rob, Lukas, Presl, Jiri, Kostun, Jan, Cremer, Isabelle, Ryska, Ales, Kroemer, Guido, Galluzzi, Lorenzo, Spisek, Radek, Fucikova, Jitka
Published 2019Text -
18
Mature dendritic cells correlate with favorable immune infiltrate and improved prognosis in ovarian carcinoma patients by Truxova, Iva, Kasikova, Lenka, Hensler, Michal, Skapa, Petr, Laco, Jan, Pecen, Ladislav, Belicova, Lucie, Praznovec, Ivan, Halaska, Michael J., Brtnicky, Tomas, Salkova, Eva, Rob, Lukas, Kodet, Roman, Goc, Jeremy, Sautes-Fridman, Catherine, Fridman, Wolf Herman, Ryska, Ales, Galluzzi, Lorenzo, Spisek, Radek, Fucikova, Jitka
Published 2018Text -
19
Predictive and prognostic significance of tumour subtype, SSTR1‐5 and e‐cadherin expression in a well‐defined cohort of patients with acromegaly by Soukup, Jiri, Hornychova, Helena, Manethova, Monika, Michalova, Kvetoslava, Michnova, Ludmila, Popovska, Lenka, Skarkova, Veronika, Cesak, Tomas, Netuka, David, Ryska, Ales, Cap, Jan, Hána, Václav, Hána, Václav, Kršek, Michal, Dvořáková, Eva, Krčma, Michal, Lazurova, Ivica, Olšovská, Věra, Starý, Karel, Vaňuga, Peter, Gabalec, Filip
Published 2021Text -
20
Sensitive detection methods are key to identify secondary EGFR c.2369C>T p.(Thr790Met) in non-small cell lung cancer tissue samples by Keppens, Cleo, Dequeker, Elisabeth M. C., Rouleau, Etienne, ’t Hart, Nils, Bubendorf, Lukas, Dufraing, Kelly, Garrec, Céline, Guéguen, Paul, Lamy, Aude, Marchetti, Antonio, Pauwels, Patrick, Ryska, Ales, Tack, Véronique, Tornillo, Luigi, Van Casteren, Kaat, von der Thüsen, Jan H., Zwaenepoel, Karen, Lissenberg-Witte, Birgit, Thunnissen, Erik, Schuuring, Ed
Published 2020Text